Bifidobacterium animalis subsp. lactis LAFTI B94
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 5 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Maltodextrine, Saccharose, Extrait de Levure, Acide ascorbique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | minimum: 6 years | 1 packet | 1 Tous les jours |
| Adultes | Not specified | 1 packet | 2 Tous les jours |
| Sous-population S/O | minimum: 4 years | 1 packet | 2 Tous les jours |
| Enfants | maximum: 6 years | 1 packet | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Ages 0 months (birth) and older: Source of probiotics. Ages 0 months (birth) and older: Helps support intestinal/gastrointestinal health. Ages 0 months (birth) and older: Could promote a favorable gut flora. Aged 0 months (birth) and older: Participates in a healthy microflora balance. Ages 4 and above: helps to relieve abdominal discomfort, such as bloating and constipation. Ages 4 and above: Helps children and adolescents with bloating and constipation in irritable bowel syndrome (IBS). Adults: In adjunct with anti-helicobacter pylori therapy, helps to improve the Helicobacter pylori eradication rate. Adults: An adjunct to physician-supervised therapy in patients with Helicobacter pylori infections. Adults: Helps to reduce adverse effects from Helicobacter pylori therapy such as loss of appetite, diarrhea, nausea, headache, dizziness, and abdominal pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occurs and/or persists beyond 3 days, discontinue use and consult a health care practitioner. This product has come into contact with milk and soy. If you have milk or soy allergy do not use this product.
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
Product record
- Other names
- Bifidobacterium animalis subsp. lactis (R0421)
- Licence holder
- Lallemand Health Solutions (Institut Rosell)
- NPN or DIN-HM
- 80077056
- Status
- Active licence
- Licence date
- 28 April 2017
- Revision date
- 22 September 2021
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80077056
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Bifidobacterium animalis subsp. lactis LAFTI B94”, https://compoatlas.com/en/supplements/canada/80077056-bifidobacterium-animalis-subsp-lactis-lafti-b94, updated 22 September 2021.